Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Organicell Regenerative Medicine, Inc.
Organicell Announces Matt Sinnreich as CEO
July 26, 2022
From
Organicell Regenerative Medicine, Inc.
Via
AccessWire
Topics
Derivatives
Exposures
Derivatives
Tickers
OCEL
Organicell Regenerative Medicine, Inc. Secures $4 Million in Funding for Clinical Trials and Agrees To Restructure Management
July 20, 2022
From
Organicell Regenerative Medicine, Inc.
Via
AccessWire
Exposures
COVID-19
Product Safety
Tickers
OCEL
Organicell Regenerative Medicine, Inc. Provides Updates of Clinical Trial Activities
December 29, 2021
From
Organicell Regenerative Medicine, Inc.
Via
AccessWire
Tickers
OCEL
Organicell Announces Positive Results of Their Expanded Access Trial for the Treatment of Mild to Moderate COVID-19 Using ZofinTM
June 15, 2021
From
Organicell Regenerative Medicine, Inc.
Via
Business Wire
Tickers
OTC
Organicell Launches Autologous Blood Derived Platform PPX™ – Patient Pure X™
June 09, 2021
From
Organicell Regenerative Medicine, Inc.
Via
Business Wire
Tickers
OTC
Organicell To Present Results Of Zofin™ Clinical Studies At The International Society Of Cell And Gene Therapy Annual Meeting
May 25, 2021
From
Organicell Regenerative Medicine, Inc.
Via
Business Wire
Tickers
OTC
Organicell Signs an Exclusive Distribution Agreement with Apex Services in Pakistan
May 19, 2021
From
Organicell Regenerative Medicine, Inc.
Via
Business Wire
Tickers
OTC
Organicell Receives Approval in Pakistan for the Use of Zofin™ for Compassionate Grounds for COVID-19
May 11, 2021
From
Organicell Regenerative Medicine, Inc.
Via
Business Wire
Tickers
OTC
Organicell Begins Up-Listing Process On NASDAQ Exchange
May 04, 2021
From
Organicell Regenerative Medicine, Inc.
Via
Business Wire
Tickers
OTC
Organicell Announces Positive Results of Initial COVID-19 Zofin™ Patient Trial in India and Trial Expansion
April 28, 2021
From
Organicell Regenerative Medicine, Inc.
Via
Business Wire
Tickers
OTC
Organicell Completes Enrollment for its Expanded Access Trial to Treat COVID-19 Patients with Zofin™
April 22, 2021
From
Organicell Regenerative Medicine, Inc.
Via
Business Wire
Tickers
OTC
Organicell Announces FDA Approval Of IND Application For The Use Of Zofin™ In The Treatment Of Osteoarthritis
April 21, 2021
From
Organicell Regenerative Medicine, Inc.
Via
Business Wire
Tickers
OTC
Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential
April 14, 2021
From
Organicell Regenerative Medicine, Inc.
Via
Business Wire
Tickers
OTC
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.